Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Language
Year range
1.
An. bras. dermatol ; 92(1): 104-106, Jan.-Feb. 2017. graf
Article in English | LILACS | ID: biblio-838022

ABSTRACT

Abstract: Psoriasis is a chronic inflammatory disease of multifactorial etiology influenced by genetic, immunological, and environmental factors. We report the case of a patient with psoriasis for more than 25 years who developed hyperuricemia and chronic tophaceous gout with unusual appearance. In psoriasis, hyperuricemia may occur by increased epidermal cell turnover, which accelerates purine metabolism and has uric acid as the product of its catabolism. The association of psoriasis with hyperuricemia can trigger the onset of gouty arthritis, and pose a greater risk of developing other inflammatory comorbidities. Therefore, it is important to periodically investigate uric acid levels in order to treat changes triggered by hyperuricemia.


Subject(s)
Humans , Male , Middle Aged , Psoriasis/complications , Hyperuricemia/etiology , Gout/etiology , Chronic Disease , Gout/pathology
2.
An. bras. dermatol ; 91(5,supl.1): 151-153, Sept.-Oct. 2016. graf
Article in English | LILACS | ID: biblio-837927

ABSTRACT

Abstract Rosacea fulminans or pyoderma faciale is a rare cutaneous disorder that usually affects women usually between the ages of 15-46. The disease is characterized by sudden onset of papules, pustules, cysts, and painful coalescing nodules with red-cyanotic centrofacial erythema. Although its etiology remains unknown, hormonal, immunological, and vascular factors have been reported. Early diagnosis and prompt treatment should minimize unsightly scars. We report a case of a 33-year-old female patient treated with traditional doses of doxycycline, with improvement of the lesions and regression of the condition in two months.


Subject(s)
Humans , Female , Adult , Doxycycline/therapeutic use , Rosacea/pathology , Rosacea/drug therapy , Facial Dermatoses/pathology , Facial Dermatoses/drug therapy , Anti-Bacterial Agents/therapeutic use , Treatment Outcome , Epidermis/pathology , Erythema/pathology , Erythema/drug therapy , Necrosis
SELECTION OF CITATIONS
SEARCH DETAIL